Menu

Consolidated Statement of Changes in Net Equity

For details see Note (24) “Equity”.

35.5 KB EXCEL
Equity capital Retained earnings Gains / losses recognized in equity
€ million General partner's equity Merck KGaA Subscribed capital Merck KGaA Capital reserves (share premium) Merck KGaA Retained ­earnings / Net retained profit Remeasurement of defined benefit plans Available-for-sale financial assets Derivative ­financial ­instruments Currency ­trans­lation ­difference Equity attributable to Merck KGaA shareholders Non-controlling interests Total equity
Balance as of January 1, 2015 397 168 3,814 6,500 – 1,275 393 1,745 11,742 59 11,801
Profit after tax 1,115 1,115 9 1,124
Other comprehensive income 115 5 – 568 969 521 3 524
Comprehensive income 1,115 115 5 – 568 969 1,636 12 1,648
Dividend payments – 129 – 129 – 4 – 133
Profit transfer to / from E. Merck KG including changes in reserves – 461 – 461 – 461
Transactions with no change of control
Changes in scope of consolidation / Other
Balance as of December 31, 2015 397 168 3,814 7,025 – 1,160 5 – 176 2,714 12,787 68 12,855
 
Balance as of January 1, 2016 397 168 3,814 7,025 – 1,160 5 – 176 2,714 12,787 68 12,855
Profit after tax 1,629 1,629 4 1,633
Other comprehensive income – 344 19 – 15 515 175 2 177
Comprehensive income 1,629 – 344 19 – 15 515 1,804 6 1,810
Dividend payments – 136 – 136 – 3 – 139
Profit transfer to / from E. Merck KG including changes in reserves – 466 – 466 – 466
Transactions with no change of control
Changes in scope of consolidation / Other – 3 3 – 10 – 10
Balance as of December 31, 2016 397 168 3,814 8,049 – 1,501 24 – 191 3,229 13,989 61 14,050